{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:27:40Z","timestamp":1793273260280,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.parkreldis.2024.106948","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:05:46Z","timestamp":1711512346000},"page":"106948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Association of intestinal inflammation and permeability markers with clinical manifestations of Parkinson's disease"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-0633","authenticated-orcid":false,"given":"Ines","family":"Rajkovaca Latic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3397-7726","authenticated-orcid":false,"given":"Zvonimir","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katica","family":"Mijatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-8871","authenticated-orcid":false,"given":"Ines","family":"Sahinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasta","family":"Pekic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-3658","authenticated-orcid":false,"given":"Domagoj","family":"Vucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Cosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6568-3306","authenticated-orcid":false,"given":"Blazenka","family":"Miskic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-3831","authenticated-orcid":false,"given":"Svetlana","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.parkreldis.2024.106948_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106948_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","article-title":"Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management","volume":"8","author":"Warnecke","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2024.106948_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.782082","article-title":"The gut-brain axis and its relation to Parkinson's disease: a review","volume":"13","author":"Klann","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2024.106948_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak's hypothesis of Parkinson's disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.106948_bib5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00415-019-09321-0","article-title":"Is Parkinson's disease a chronic low-grade inflammatory bowel disease?","volume":"267","author":"Rolli-Derkinderen","year":"2020","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106948_bib6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1136\/gutjnl-2012-303957","article-title":"Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring","volume":"62","author":"Benitez","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.parkreldis.2024.106948_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2024.106948_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fnins.2019.00992","article-title":"Fecal calprotectin as a marker of the gut immune system activation is elevated in Parkinson's disease","volume":"13","author":"Mulak","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.parkreldis.2024.106948_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689723","article-title":"Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson's disease","volume":"15","author":"Dumitrescu","year":"2021","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106948_bib10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.106948_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.parkreldis.2015.08.005","article-title":"An analysis of the cognitive items of the Movement Disorder Society checklist for the diagnosis of dementia in patients with Parkinson's disease","volume":"21","author":"Oliveira","year":"2015","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"9","key":"10.1016\/j.parkreldis.2024.106948_bib12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106948_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.870090112","article-title":"Unified Parkinson's disease rating scale characteristics and structure. The cooperative multicentric group","volume":"9","author":"Mart\u00ednez-Mart\u00edn","year":"1994","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106948_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/mdc3.13122","article-title":"Prevalence of non-motor symptoms and non-motor fluctuations in Parkinson's disease using the MDS-NMS","volume":"8","author":"Rodriguez-Blazquez","year":"2020","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106948_bib15","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.20153","article-title":"Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT","volume":"19","author":"Visser","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.106948_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sleep.2016.06.026","article-title":"Clinically relevant cut-off values for the Parkinson's Disease Sleep Scale-2 (PDSS-2): a validation study","volume":"24","author":"Muntean","year":"2016","journal-title":"Sleep Med."},{"issue":"3\u20134","key":"10.1016\/j.parkreldis.2024.106948_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000532115","article-title":"Ecological validity of the Montreal cognitive assessment in non-demented Parkinson's disease patients","volume":"22","author":"Aiello","year":"2022","journal-title":"Neurodegener. Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106948_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.23184","article-title":"Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale","volume":"26","author":"Leentjens","year":"2011","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106948_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1590\/1516-4446-2012-1048","article-title":"Psychometric properties of the Beck depression inventory-II: a comprehensive review","volume":"35","author":"Wang","year":"2013","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.parkreldis.2024.106948_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cca.2020.08.025","article-title":"Calprotectin in inflammatory bowel disease","volume":"510","author":"Khaki-Khatibi","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"24","key":"10.1016\/j.parkreldis.2024.106948_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415962","article-title":"Increased intestinal permeability and stool zonulin, calprotectin and beta-defensin-2 concentrations in allogeneic hematopoietic cell transplantation recipients","volume":"23","author":"Tyszka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106948_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106948_bib24","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1007\/s11695-016-2222-0","article-title":"Fecal calprotectin, elastase, and alpha-1-antitrypsin levels after Roux-en-Y gastric bypass; calprotectin is significantly elevated in the majority of patients","volume":"26","author":"Boerlage","year":"2016","journal-title":"Obes. Surg."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106948_bib25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s10096-013-1905-x","article-title":"Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection","volume":"32","author":"Boone","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.106948_bib26","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cgh.2020.09.034","article-title":"Activation of the innate immune system in children with irritable bowel syndrome evidenced by increased fecal human \u03b2-defensin-2","volume":"19","author":"Shulman","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106948_bib27","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/biom12121781","article-title":"Impact of biometric patient data, probiotic supplementation, and selected gut microorganisms on calprotectin, zonulin, and sIgA concentrations in the stool of adults aged 18-74 years","volume":"12","author":"Jendraszak","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106948_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202400960X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202400960X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T08:31:03Z","timestamp":1717317063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202400960X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"alternative-id":["S135380202400960X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106948","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of intestinal inflammation and permeability markers with clinical manifestations of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106948"}}